BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Scott Weiner appointed to Strategic Advisory Board of Florida Institute for the Commercialization of Public Research
News | 05. 14. 2009
The Florida Institute for the Commercialization of Public Research (The Institute) today announced the formation of its Strategic Advisory Board; 15 distinguished industry experts who will provide counsel on technical challenges associated with raising early stage capital and technology commercialization.
